Yasushi Ohno

1.3k total citations
61 papers, 1.0k citations indexed

About

Yasushi Ohno is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yasushi Ohno has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Yasushi Ohno's work include Nausea and vomiting management (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Yasushi Ohno is often cited by papers focused on Nausea and vomiting management (9 papers), Lung Cancer Treatments and Mutations (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Yasushi Ohno collaborates with scholars based in Japan, Mexico and Spain. Yasushi Ohno's co-authors include Hisayoshi Fujiwara, Shinya Minatoguchi, Genzou Takemura, Takako Fujiwara, Kazunori Fukuda, Seigou Akao, Toshihiro Asai, Norihiko Funaguchi, Motohiro WATANABE and Norio Yasuda and has published in prestigious journals such as Clinical Cancer Research, American Journal Of Pathology and Biochemical Pharmacology.

In The Last Decade

Yasushi Ohno

57 papers receiving 978 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasushi Ohno Japan 19 326 259 135 111 94 61 1.0k
Devipriya Nagarajan India 19 378 1.2× 160 0.6× 129 1.0× 29 0.3× 55 0.6× 36 1.1k
Srinivasan Kalayarasan India 18 504 1.5× 255 1.0× 156 1.2× 19 0.2× 45 0.5× 20 1.2k
Toshihiro Asai Japan 13 208 0.6× 117 0.5× 49 0.4× 68 0.6× 73 0.8× 22 659
Jie Liao United States 23 635 1.9× 76 0.3× 206 1.5× 99 0.9× 133 1.4× 37 1.6k
Siranoush Shahrzad Canada 12 616 1.9× 65 0.3× 152 1.1× 90 0.8× 38 0.4× 17 1.4k
Subapriya Rajamanickam United States 17 805 2.5× 202 0.8× 165 1.2× 105 0.9× 52 0.6× 24 1.3k
Anna L. Greenshields Canada 16 550 1.7× 142 0.5× 159 1.2× 14 0.1× 75 0.8× 41 1.2k
Rafal Swiercz United States 14 575 1.8× 67 0.3× 184 1.4× 85 0.8× 41 0.4× 16 1.3k
Yu‐Jen Chiu Taiwan 17 409 1.3× 54 0.2× 136 1.0× 29 0.3× 75 0.8× 59 1.0k
Aya Naiki‐Ito Japan 25 870 2.7× 283 1.1× 245 1.8× 30 0.3× 143 1.5× 99 1.7k

Countries citing papers authored by Yasushi Ohno

Since Specialization
Citations

This map shows the geographic impact of Yasushi Ohno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasushi Ohno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasushi Ohno more than expected).

Fields of papers citing papers by Yasushi Ohno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasushi Ohno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasushi Ohno. The network helps show where Yasushi Ohno may publish in the future.

Co-authorship network of co-authors of Yasushi Ohno

This figure shows the co-authorship network connecting the top 25 collaborators of Yasushi Ohno. A scholar is included among the top collaborators of Yasushi Ohno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasushi Ohno. Yasushi Ohno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iihara, Hirotoshi, et al.. (2023). Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer. Anticancer Research. 43(2). 725–732. 4 indexed citations
3.
Iihara, Hirotoshi, Hironori Fujii, Yuka Sasaki, et al.. (2023). Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy. Anticancer Research. 43(3). 1301–1307. 3 indexed citations
4.
Shimokawa, Mototsugu, Hirotoshi Iihara, Yukiyoshi Fujita, et al.. (2021). Low-Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin-Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial. The Oncologist. 26(6). e1066–e1072. 5 indexed citations
5.
Iihara, Hirotoshi, Hironori Fujii, Yuka Sasaki, et al.. (2021). Primary Prophylaxis of Febrile Neutropenia With Pegfilgrastim in Small-cell Lung Cancer Patients Receiving Amrubicin as Second-line Therapy. Anticancer Research. 41(3). 1615–1620. 3 indexed citations
8.
Sasaki, Yuka, et al.. (2019). Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer. Respiratory Medicine Case Reports. 28. 100871–100871. 22 indexed citations
9.
Iihara, Hirotoshi, Norihiko Funaguchi, Yuka Sasaki, et al.. (2017). Efficacy of Single-dose First-generation 5-HT3 Receptor Antagonist and Dexamethasone for Preventing Nausea and Vomiting Induced by Low-dose Carboplatin-based Chemotherapy. Anticancer Research. 37(4). 1965–1970. 1 indexed citations
10.
Miyazaki, Nagisa, et al.. (2015). Acupuncture Treatment for Dyspnea due to Combined Pulmonary Fibrosis and Emphysema: A Case Report. The Journal of Alternative and Complementary Medicine. 21(12). 804–809. 3 indexed citations
11.
Ju, Yang, Yasushi Ohno, Hitoshi SOYAMA, & Masumi SAKA. (2009). Electrical Characterization of Doped Silicon Using High-Frequency Electromagnetic Waves. Journal of Material Science and Technology. 20. 123–124. 3 indexed citations
12.
Ohno, Yasushi, Yusuke Tsuge, Masanori Kawasaki, et al.. (2009). Use of Multidetector Row CT to Evaluate the Need for Bronchial Arterial Embolization in Hemoptysis Patients. Respiration. 80(1). 24–31. 32 indexed citations
13.
Ohno, Yasushi, et al.. (2009). Effect of Intermittent Systemic Corticosteroid on Bone Metabolism in Bronchial Asthma Patients. Journal of Asthma. 46(2). 142–146. 9 indexed citations
14.
Suzuki, Masao, Yasushi Ohno, Masato Egawa, et al.. (2008). The Effect of Acupuncture in the Treatment of Chronic Obstructive Pulmonary Disease. The Journal of Alternative and Complementary Medicine. 14(9). 1097–1105. 48 indexed citations
15.
Sawada, Masahiro, Yasushi Ohno, Norihiko Funaguchi, et al.. (2007). THE FAS/FAS-LIGAND PATHWAY DOES NOT MEDIATE THE APOPTOSIS IN ELASTASE-INDUCED EMPHYSEMA IN MICE. Experimental Lung Research. 33(6). 277–288. 12 indexed citations
16.
Fukuda, Kazunori, Seigou Akao, Yasushi Ohno, Kazuya Yamashita, & Hisayoshi Fujiwara. (2001). Inhibition by costunolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Cancer Letters. 164(1). 7–13. 35 indexed citations
17.
Kawada, Miki, Yasushi Ohno, Toshihiro Asai, et al.. (2001). Anti-tumor effect of gallic acid on LL-2 lung cancer cells transplanted in mice. Anti-Cancer Drugs. 12(10). 847–852. 149 indexed citations
18.
Maruyama, Rumi, Genzou Takemura, Takuma Aoyama, et al.. (2001). Dynamic Process of Apoptosis in Adult Rat Cardiomyocytes Analyzed Using 48-Hour Videomicroscopy and Electron Microscopy. American Journal Of Pathology. 159(2). 683–691. 32 indexed citations
19.
WATANABE, Motohiro, Kenshi Nagashima, Yoshihiro Uno, et al.. (2001). Relationship between thallium-201 myocardial SPECT and findings of endomyocardial biopsy specimens in dilated cardiomyopathy. Annals of Nuclear Medicine. 15(1). 13–19. 7 indexed citations
20.
Fukuda, Kazunori, Yuko Hibiya, Michihiro Mutoh, et al.. (2000). Inhibition by parthenolide of phorbol ester-induced transcriptional activation of inducible nitric oxide synthase gene in a human monocyte cell line THP-1. Biochemical Pharmacology. 60(4). 595–600. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026